Holen Sie sich die Stockscreener-App
0.966
1.68%
0.016
Handel nachbörslich:
.95
-0.016
-1.66%
Biofrontera Inc Aktie (BFRI) Neueste Nachrichten
Biofrontera Inc. Equity Warrant Attempts Reversal From Key SupportJuly 2025 Big Picture & Fast Moving Market Watchlists - thegnnews.com
Biofrontera Q2 Revenue Jumps 15% - The Motley Fool
Transcript : Biofrontera Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Earnings call transcript: Biofrontera Q2 2025 sees revenue growth, net loss - Investing.com
Analyzing net buyer seller activity in Biofrontera Inc.2025 Historical Comparison & Stepwise Swing Trade Plans - Newser
Can swing trading help recover from Biofrontera Inc. Equity Warrant lossesEarnings Miss & Breakout Confirmation Alerts - Newser
Using Ichimoku Cloud for Biofrontera Inc. technicalsPortfolio Value Report & Verified Chart Pattern Signals - Newser
Biofrontera 2025 Q2 Earnings Net Loss Widens 1971.6% - AInvest
Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update - GlobeNewswire
Biofrontera Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biofrontera Reports Strong Growth as New US Rights Deal Cuts Production Costs by Over 50% - Stock Titan
Biofrontera Inc. SEC 10-Q Report - TradingView
Will Biofrontera Inc. see short term momentumOil Prices & Detailed Earnings Play Strategies - Newser
Can Biofrontera Inc. keep up with sector leaders2025 Sector Review & Community Consensus Trade Signals - thegnnews.com
Can Biofrontera Inc. recover in the next quarterQuarterly Profit Review & Consistent Profit Trading Strategies - Newser
Intraday pattern recognizer results for Biofrontera Inc. Equity WarrantMarket Sentiment Summary & Risk Controlled Stock Pick Alerts - Newser
Published on: 2025-08-13 16:20:55 - 선데이타임즈
Intraday pattern recognizer results for Biofrontera Inc.Bull Run & Free Expert Approved Momentum Trade Ideas - Newser
Using Ichimoku Cloud for Biofrontera Inc. technicals [Market Movement Recap]Safe Entry Momentum Tips - Newser
Order flow analysis tools used on Biofrontera Inc. Equity WarrantCapital Growth Summary Over Five Years - Newser
Smart tools for monitoring Biofrontera Inc. Equity Warrant’s price action [Weekly Trade Review]AI Driven Stock Movement Reports - Newser
Tools to monitor Biofrontera Inc. recovery probabilityWall Street Watch & Low Risk Growth Stock Ideas - Newser
A Look at Biofrontera's Upcoming Earnings Report - 富途牛牛
How Biofrontera Inc. Equity Warrant stock performs during market volatilityFree Smart Trend Trading with Weekly Signals - Newser
Biofrontera Appoints New Chief Commercial Officer - The Globe and Mail
Trend analysis for Biofrontera Inc. this weekFree Accurate Buy Point for Momentum Stocks - Newser
What makes Biofrontera Inc. stock price move sharplyShort Term Trading Opportunity Watch Sees Shift - beatles.ru
Real time social sentiment graph for Biofrontera Inc. Equity WarrantFree Buy Alerts With Low Risk Confirmation - Newser
Smart tools for monitoring Biofrontera Inc. Equity Warrant’s price actionFree Short Term Buy List With Stop Protection - Newser
Using AI based signals to follow Biofrontera Inc. Equity WarrantFree Early Breakout Entry Point Notifications - Newser
Is it time to cut losses on Biofrontera Inc. Equity WarrantAI Triggered Buy Zone Forecast System - Newser
Is Biofrontera Inc. meeting your algorithmic filter criteriaDaily Stock Watch Summary with Key Insights - Newser
Exit strategy if you’re trapped in Biofrontera Inc.Ten-Year Sector Performance and Summary Analysis - Newser
Technical signs of recovery in Biofrontera Inc.Free High Accuracy Alerts for ROI Traders - Newser
Does Biofrontera Inc. meet Warren Buffett’s criteriaNext Wave Growth Stocks - thegnnews.com
Statistical indicators supporting Biofrontera Inc.’s strength3-Year Equity Summary With Setup Insights - Newser
Biofrontera Inc. Appoints George Jones as Chief Commercial Officer - GlobeNewswire
Biofrontera Inc.’s volatility index tracking explainedAI Generated Momentum Stock Forecast Guide - Newser
How institutional ownership impacts Biofrontera Inc. Equity Warrant stockCommunity Picked Stocks with Trade Insights - Newser
Biofrontera appoints George Jones as chief commercial officer - Investing.com
Biofrontera appoints George Jones as chief commercial officer By Investing.com - Investing.com Australia
Biofrontera Strengthens Leadership: New CCO to Drive Growth After Major Ameluz Rights Acquisition - Stock Titan
What MACD signals say about Biofrontera Inc. Equity WarrantLow Risk Strategy with Smart Entry Zones - Newser
Risk adjusted return profile for Biofrontera Inc. analyzedFree Triple Digit Growth Focused Trade Plan - Newser
Is Biofrontera Inc. Equity Warrant stock entering bullish territoryOversold Stock Bounce Playbook Generator - Newser
Is Biofrontera Inc. Equity Warrant stock poised for growthAI Triggered Buy Zone Forecast System - Newser
Advanced analytics toolkit walkthrough for Biofrontera Inc. Equity WarrantChart Confirmation Setup with ROI Signals - Newser
Is Biofrontera Inc. building a consolidation baseMarket Sentiment Tracker with Smart Alerts - Newser
Biofrontera BFRI 2025Q2 Earnings Preview Upside Potential with Model Fusion Strategies - AInvest
Biofrontera WRT BFRIW 2025Q2 Earnings Preview Downside Risk Amid Market Uncertainty - AInvest
Will a bounce in Biofrontera Inc. Equity Warrant offer an exitFree Entry Plan for Oversold Reversal Stocks - Newser
What is Biofrontera Inc. s revenue forecastDaily Trading Strategy Update - thegnnews.com
How high can Biofrontera Inc. stock goGrowth Watchlist for Long Term Positioning - Newser
Why Biofrontera Inc. Equity Warrant stock attracts strong analyst attentionPredictable Entry Strategy With Technical Backing - Newser
What technical models suggest about Biofrontera Inc. Equity Warrant’s comebackInsider Strategy for High Conviction Picks - Newser
Is Biofrontera Inc. stock entering bullish territoryFree Value Investing Picks With Stability - Newser
AI Trend Models Suggest Bounce for Biofrontera Inc.Growth Based Stock Signal Screener Updated - beatles.ru
1.29%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):